Protein (1)
Launched (1)
Human (1)
His Tag & Avi Tag (1)
Biotin-labeled (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
HLM-H82Ev | HEK293 | Biotinylated Human HLA-A*26:01&B2M Monomer Protein (Peptide free, MALS verified) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Latozinemab | AL-001; GSK-4527223 | Phase 3 Clinical | Alector Inc, Glaxosmithkline Plc | Bipolar Disorder; Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Neurodegenerative Diseases | Details |
| VES-001 | VES-001; VES001 | Phase 1 Clinical | Vesper Bio APS | Dementia; Frontotemporal Dementia | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



